Go to Top

June 2014

Jobseekers ‘can be deterred by first impressions’

New research reveals more than two-thirds of jobseekers would turn down an offer of employment if their first impression of an organisation is substandard. This is according to Monster.co.uk, which has published data on the factors influencing interviewees' decisions. The findings could help HR professionals ensure the recruitment process isn't jeopardised by external factors. Appearances play a significant role in decision-making, with 35 per cent of interviewees saying they would …Read More

Scientists discover ribosome ‘missing link’

Researchers at the University of California (UC) San Diego have discovered the 'missing link' in the system that enables animal cells to produce ribosomes. The discovery could give biologists a better understanding of how to limit uncontrolled cell growth, such as cancer, that might be regulated by controlling the output of ribosomes. It will also lead to the revision of basic textbooks on molecular biology. Ribosomes contained within each cell …Read More

New research ‘could help combat atherosclerosis’

Researchers have identified a molecule that plays a role in exacerbating atherosclerosis and could provide a target for new therapies. Scientists at the University of Texas (UT) Southwestern Medical Center found that a molecule known as 27HC (27-hydroxycholesterol) promotes the formation of atherosclerotic plaques, which can lead to cardiovascular disease. Atherosclerosis involves the build-up of lesions (or plaques) formed from lipids, such as cholesterol and fatty acids. If these rupture, they …Read More

HR ‘failing to monitor candidates’ experiences’

New research reveals many employers are failing to monitor candidates' experiences when it comes to recruitment. Up to 60 per cent of HR professionals are doing nothing to monitor the impact of their hiring experience, even though 70 per cent understand the importance of this factor to the recruitment process. Some 64 per cent of those surveyed in the CEB Global Assessment Trends Report for 2014 said it would become …Read More

New T cell therapy protects immunodeficient patients

Scientists at Technische Universitat Munchen (TUM), together with colleagues at Frankfurt, Wurzburg and Gottingen, have discovered a new method to protect patients against viruses following bone marrow transplants.  Immune system cells are created from stem cells in the bone marrow. In diseases affecting the bone marrow, such as leukemia, degenerate cells must be destroyed using radiation or chemotherapy. Stem cells from a healthy donor are required to replace the cells …Read More

HR to raise technology investment

A new survey of HR departments reveals many firms are looking to strike a balance between people, process and technology. Towers Watson's 2014 HR Service Delivery and Technology Survey shows one in three companies are set to boost their spending on HR technology in the coming year compared with the previous 12 months. Some 23 per cent plan to raise their spending by as much as ten per cent, while …Read More

Type 1 diabetes reversal ‘could one day benefit humans’

Researchers have succeeded in reversing type 1 diabetes in mice and their efforts could help to combat the disease in humans. Type 1 diabetes currently affects five per cent of all people with diabetes, according to the American Diabetes Association. It is usually diagnosed in children and young adults. The incidence of the disease has increased since the mid-20th century and this could be due to under-stimulation of innate immune …Read More

Auto-enrolment is many firms’ ‘biggest challenge’

A new report has revealed many employers view auto-enrolment as the biggest challenge their organisation will face over the coming years. Auto-Enrolment: Expectations versus Reality, commissioned by Buzzacott Employee Solutions and Meridian West, states that four in ten employers have such a view of auto-enrolment, HR Magazine reports. Those who have been through the process found it more arduous than expected, the study reveals, with 34 per cent saying it …Read More

Cancer drug raises levels of vascular-protective gene

An existing drug that is used to treat cancer patients has been found to be effective in protecting people from vascular clots.  Bortezomib (Velcade), which is used to treat multiple myeloma, was approved for use by the US Food and Drug Association in 2012. As well as attacking cancer cells, it has been found to help prevent clot development common to many forms of the disease. The anti-thrombotic effects of …Read More

Employers ‘could face flexible working application surge’

Employers could face a surge in flexible working applications when the new legislation comes into effect later in the year. A new survey conducted by YouGov reveals 26 per cent of British workers (excluding sole traders) are likely to request flexible working arrangements, HR review reports. Some 69 per cent of the working population has never made a flexible working request, with 13 per cent of these reluctant to do …Read More